Literature DB >> 4296291

Antibody to rhinovirus in human sera. II. Heterotypic responses.

W F Fleet, R G Douglas, T R Cate, R B Couch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4296291     DOI： 10.3181/00379727-127-32725

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  9 in total

1.  Cross-protection among feline caliciviruses.

Authors:  C Povey; J Ingersoll
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

2.  Absence of heterologous antibody responses in human volunteers after rhinovirus vaccination. (Brief report).

Authors:  E J Stott; C Draper; P B Stons; D A Tyrrell
Journal:  Arch Gesamte Virusforsch       Date:  1969

Review 3.  Infectious diseases. Annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1969-07       Impact factor: 2.401

Review 4.  Replication of rhinoviruses.

Authors:  B E Butterworth; R R Grunert; B D Korant; K Lonberg-Holm; F H Yin
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

5.  Isolation of rhinovirus intertypes related to either rhinoviruses 12 and 78 or 36 and 58.

Authors:  L M Halfpap; M K Cooney
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

6.  Cross relationships among 37 rhinoviruses demonstrated by virus neutralization with potent monotypic rabbit antisera.

Authors:  M K Cooney; G E Kenny; R Tam; J P Fox
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

7.  The rhinoviruses of man.

Authors:  M Fiala; L B Guze
Journal:  Calif Med       Date:  1970-05

8.  Rhinoviruses.

Authors:  J M Gwaltney
Journal:  Yale J Biol Med       Date:  1975-03

9.  Human rhinovirus spatial-temporal epidemiology in rural coastal Kenya, 2015-2016, observed through outpatient surveillance.

Authors:  John Mwita Morobe; Joyce U Nyiro; Samuel Brand; Everlyn Kamau; Elijah Gicheru; Fredrick Eyase; Grieven P Otieno; Patrick K Munywoki; C N Agoti; D J Nokes
Journal:  Wellcome Open Res       Date:  2019-03-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.